NASHUA, N.H.,
Nov. 18, 2019 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that Michael Klein, Chairman and Chief Executive Officer, will
present a corporate overview at the Canaccord Genuity MedTech & Diagnostics
Forum, taking place Thursday, November 21st in New York City.

Presentation
Details:

Date: 

Thursday, November 21, 2019

Time: 

10:00am Eastern Time

Webcast:

http://wsw.com/webcast/canaccord37/icad/

About
iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.

Contact:

Media Inquiries:
Jessica Burns, iCAD 
+1-201-423-4492
jburns@icadmed.com 

Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com